Inhalation therapy of equine respiratory disorders

Equine Veterinary Education

Volumn 11, Issue 3, 1999, Pages 124-131

  Duvivier, Dominique H ^b   Votion, Dominique ^b   Roberts, C A ^a   Art, Tatiana ^b   Lekeux, P ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

EID: 0033419092     PISSN: 09577734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-3292.1999.tb00933.x     Document Type: Article

References (70)

1. Alabaster, V.A. and Moore, B.A. (1993) Drug intervention in asthma present and future. Thorax 48, 176-182.
2. Ammann, V.J., Vrins, A.A. and Lavoie, J.-P. (1998) Effects of inhaled beclomethasone dopropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD). Equine vet. J. 30, 152-157.
3. Atkins, P.J., Barker, N.P. and Mathisen, D. (1992) The design and development of inhalation drug delivery systems. In: Pharmaceutical Inhalation Aerosol Technology, Ed: A.J. Hickey, Marcel Dekker Inc., New York. pp 155-185.
4. Barnes, P.J. (1995) Molecular mechanisms of anti-asthma therapy. Ann. Med. 27, 531-535.
5. Barnes, P.J. and Pedersen, S. (1993) Efficacy and safety of inhaled corticosteroids in asthma. Am. Rev. respir. Dis. 148, 51-526.
6. Beasley, C.R.W., Rafferty, P. and Holgate, S.T. (1987) Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebulizer solution. Br. med. J. 294, 1197-1198.
7. Beech, J. (1991) Chronic obstructive pulmonary disease. Vet. Clin. North Am.: Equine Pract. 7, 79-91.
8. Berti, F., Rossoni, O., Robuschi, M. and Mandelli, V. (1995) Protective effect of fluroxemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. Drug Res. 45-2, 1098-1102.
9. Bianco, S., Pieroni, M.G., Refini, R.M., Rottoli, L. and Sestini, P. (1989) Protective effects of inhaled frusemide on allergen-induced early and late asthmatic reactions. New Engl. J. Med. 321, 1069.
10. Bianco, S., Vaghi, A., Robushi, M. and Pasargiklian, M. (1988) Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet 2, 252.
11. Bohadana, A.B., Peslin, R., Teculescu, D., Polu, J.M., Belville, F. and Massin, N. (1980) The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction. Bull. Eur. Physiopathol. Respir. 16, 13-24.
12. Brain, J.D. and Valberg, P.A. (1979) Deposition of aerosol in the respiratory tract. Am. Rev. respir. Dis. 20, 1325-1367.
13. Broadstone, R.V., Robinson, N.E., Gray, P.R., Woods, P.S.A. and Derksen, F.J. (1991a) Effect of frusemide on ponies with recurrent airway obstruction. Pulm. Pharmacol. 4, 203-208.
14. Broadstone, R.V., LeBlanc, P.H., Derksen, F.J. and Robinson, N.E. (1991b) In vitro responses of airway smooth muscle from horses with recurrent airway obstruction. Pulm. Pharmacol. 4, 191-202.
15. Check, W.A. and Kaliner, M.A. (1990) Pharmacology and pharmacokinetics of topical corticosteroid derivative used for asthma therapy. Am. Rev. respir. Dis. 141, S44-S51.
16. Clark, T.J.H. (1982) Safety of inhaled corticosteroids. Eur. J respir. Dis. 635,122, 235-242.
17. Clarke, A.F. (1991) Practicalities of nebulization. Equine vet. Educ. 3, 45-49.
18. Clarke, S.W. and Newman, S.P. (1984) Therapeutic aerosols 2 - Drugs available by the inhaled route. Thorax 39, 1-7.
19. Clarke, S.W. and Pavia, D. (1988) Defense mechanisms and immunology, deposition and clearance. In: Textbook of Respiratory Medicine, Ed: J.A. Nadel, W.B. Saunders Company, Philadelphia. pp 313.
20. Clay, M.M., Pavia, D., Newman, S.P. and Clarke, S.W. (1983a) Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 38, 755-759.
21. Clay, M.M., Pavia, D., Newman, S.P., Lennard-Jones, T. and Clarke, S.W. (1983b) Assessment of jet nebulizers for lung aerosol therapy. Lancet 2, 592-594.
22. Cushley, M.J. and Holgate, S.T. (1983) Efficacy of inhaled methyl xanthines as bronchodilators in asthma. Thorax 38, 223.
23. Derksen, F.J. (1993) Chronic obstructive pulmonary disease (heaves) as an inflammatory condition Equine vet. J. 25, 257-258.
24. Derksen, F.J. (1995) Use of bronchodilator therapy in the horse. In: Proceedings of the Swiss Veterinary 4th Congrès de Médecine et Chirurgie Equine de Genève, 11-S, 106-107.
25. Derksen, -F.J., Robinson, N.E. and Berney, C.E. (1992) Aerosol pirbuterol: bronchodilator activity and side effects in ponies with recurrent airway obstruction (heaves). Equine vet. J. 24, 107-112.
26. Derksen, F.J., Olszewski, M., Robinson, N.E., Berney, C., Lloyd, J.W., Hakala, J., Matson, C. and Ruth, D. (1996) Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'. Equine vet. J. 28, 306-310.
27. Dixon, P.M. (1992) Therapeutics of the respiratory tract. In: Current Therapy in Equine Medicine 3, Ed: N.E. Robinson, W.B. Saunders Company, Philadelphia. pp 303-310.
28. Ducharme, O. and Fubini, S.L. (1983) Gastrointestinal complications associated with the use of atropine in horses. J. Am. vet. med. Ass. 182, 229-231.
29. Duvivier, D.H., Votion, D., Vandenput, S., Art, T. and Lekeux, P. (1997a) Technical validation of a face mask adapted for dry powder inhalation in the equine species. Equine vet. J. 29, 471-476.
30. Duvivier, D.H., Votion, D., Vandenput, S., Art, T. and Lekeux, P. (1997b) Airway response of horses with COPD to dry powder inhalation of ipratropium bromide. Vet. J. 154, 149-153.
31. Flament, M.-P., Leterme, P. and Gayot, A.T. (1995) Factors influencing nebulizing efficiency. Drug Dev. Ind Pharm. 21, 2263-2285.
32. Geor, R.J. (1995) Performance-limiting conditions of the lungs. In: The Horse. Diseases & Clinical Management, Vol. 1, Eds: C.N. Kobluk, T.R. Ames and R.J. Geor, W.B. Saunders Company, Philadelphia. pp 263-273.
33. Gray, P.R., Derksen, J., Robinson, N.E., Carpenter-Deyo, L.J., Johson, H.G. and Roth, R.A. (1989) The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. Am. Rev. respir. Dis. 140,154-160.
34. Gross, N.J. and Skorodin, M.S. (1984) Anticholinergic, antimuscarinic bronchodilators. Am. Rev. respir. Dis. 129, 856-870.
35. Hoffman, A.M., Viel, L. and Tesarowski, D.B. (1993) Management of severe obstructive pulmonary disease with inhaled bronchodilator treatment in a horse. Can. vet. J. 34, 493-495.
36. Hoffman, A.M. (1997) Inhaled medications and bronchodilator in the horse. Vet. Clin. N. Am.: Equine Pract. 13, 519-530.
37. Klein, H.-J. and Deegen, E. (1985) Non-specific airway hyperreactivity in horses and the influence of corticosteroids. In: Lung Function and Respiratory Diseases in the Horse, Eds: E. Deegen and R.E. Beadle, Hippiatrika-Verlagsgesellschaft, Calw, West-Germany. pp 61-64.
38. König, P. (1984) Inhaled corticosteroids: use and abuse? Allergy Proc. 5, 37-38.
39. Lapointe, J.-M., Lavoie, J.-P. and Vrins, A. (1993) Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am. J. vet. Res. 54, 1310-1316.
40. Mann, J.S., Howarth, P.H. and Holgate, S.T. (1984) Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br. med. J. 289, 469.
41. McKiernan, B.C., Koritz, G.D., Scott, J., Berney, C. and Robinson, N.E. (1990) Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease. Equine vet. J. 22, 194-197.
42. Moore, B.R. (1996) Lower respiratory tract disease. Vet. Clin. N. Am.: Equine Pract. 12, 457-471.
43. Morris, H.G. (1987) An update in treatment of asthma with inhaled steroids. Allergy Proc. 8, 85-94.
44. Morrow, P.E. (1986) Factors determining hygroscopic aerosol deposition in airways. Physiol. Rev. 66, 330-376
45. Murphy, J.L., McPherson, E.A. and Dixon, P.M. (1980) Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses. Equine vet. J. 12, 10-14.
46. Pakes, G.E., Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. (1980) Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20, 237-266.
47. Pavia, D., Thomson, M.L., Clarke, S.W. and Shannon, H.S. (1977) Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax 32, 194-197.
48. Pavia, D., Bateman, J.R.M. and Clarke, S.W. (1980) Deposition and clearance of inhaled particles. Bull. Eur. Physiopath. Respir. 16, 335-366.
49. Pearson, E.G. and Riebold, T.W. (1989) Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. J. Am. vet. med. Ass. 194, 1287-1291.
50. Raabe, O.G. (1976) In: Fine Particles, New York Academy Press, pp 57-110.
51. Radermecker, M. (1987) L'aérosolthérapie. Revue Médicale de Liege XLII, 10, 433-436.
52. Robinson, N.E., Derksen, F.J., Berney, C. and Goossens, L. (1993) The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine vet. J. 25, 299-303.
53. Rose, R.J. and Hodgson, D.R. (Eds) (1993) Lower respiratory tract diseases. In: Manual of Equine Practice, W.B. Saunders Company, Philadelphia. pp 160-169.
54. Rubie, S., Robinson, N.E., Stoll, M., Broadstone, R.V. and Derksen, F.J. (1993) Flunixin meglumine blocks frusemide-induced bronchodilatation in horses with chronic obstructive pulmonary disease. Equine vet. J. 25, 138-142.
55. Ruoff, W.W. (1988) Fungal pneumonias in horses. Proc. Am. Ass. equine Practnrs. 34, 423.
56. Silverman, M. (1990) Aerosol therapy in the newborn. Arch. Dis. Child. 65, 906-908.
57. Soma, L.R., Beech, J. and Gerber, N.H. (1987) Effects of cromolyn in horses with chronic obstructive pulmonary disease. Vet. Res. Commun. 11, 339-351.
58. Stahlofen, W., Gebhart, J. and Heyder, J. (1980) Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am. Ind. Hyg. Ass. J. 41, 385-398.
59. Sustronck, B. (1995) Farmakokinetische, Experimentele en Klinische Bijdrage tot de Behandeling van Bronchopeumonie bij Kalveren. Thèse de doctorat, Ghent.
60. Tesarowski, D.B., Viel, L., McDonell, W.N. and Newhouse, M.T. (1994) The rapid and effective administration of a β2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can. vet. J. 35, 170-173.
61. Timsina, M.P., Martin, G.P., Marriott, C., Ganderton, D. and Yianneskis M. (1994) Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101, 1-13.
62. Thompson, D.C. (1992) Pharmacology of therapeutic aerosols. In: Pharmaceutical Inhalation Aerosol Technology, Ed: A.J. Hickey, Marcel Dekker Inc., New York. pp 29-59.
63. Thomson, J.R. and McPherson, E.A. (1981) Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horse. Equine vet. J. 13, 243-246.
64. Turgut, K. and Sasse, H.H.L. (1989) Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease. Vet. Rec. 125, 526-530.
65. Vidgren, M., Kärkkäinen, A., Karjalainen, P., Nuutinen, J. and Paronen, P. (1988) In vitro and in vivo deposition of drug particles inhaled from pressurized aerosol and dry powder inhaler. Drug Dev. Ind. Pharm. 14, 2649-2665.
66. Viel, L. and Tesarowski, D.B. (1994) Radioaerosol deposition in equids. Proc. Am. Ass. equine Practnrs. 40, 93-94.
67. Votion, D., Ohafir, Y., Art, T. and Lekeux, P. (1997) Aerosol deposition in the equine lungs following ultrasonic and jet aerosol delivery system. Equine vet. J. 29, 388-393.
68. Wilson, W.D. (1992) Foal Pneumonia. In: Current Therapy in Equine Medicine, Ed: N.E. Robinson, W.B. Saunders Company, Philadelphia. pp 466-473.
69. Windom, H., Burgess, C., Crane, J. and Beasley, R. (1990) Airways effects of inhaled chlorbutol in asthmatic subjects. Thorax 45, 345.
70. Yu, M., Wang, Z., Robinson, N.E. and Derksen, F.J. (1992) The inhibitory effect of frusemide on the contractile response of equine trachealis to cholinergic nerve stimulation. Pulm. Pharmacol. 5, 233-238.